Riskpilot← Back to searchSign inGet full accessMedsys Sverige AB
ABActiveOrg 5568959703Valsgärdevägen 2Computer programming activities · NACE 6210Est. 20120 employees
Revenue 2024
—
EBITDA margin
—
-22% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -7K
-22% vs 2023
| Revenue | — | — |
| EBITDA | SEK -7K | -22% |
| Net profit | SEK -7K | -22% |
| Total assets | SEK 96K | +4% |
| Equity | SEK 96K | -7% |
| Employees | 0 | — |
Legal name
Medsys Sverige AB
Org number
5568959703
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
13 juni 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Företaget ska bedriva medicinsk konsultverksamhet och utvecklingsarbete inom hälso- och sjukvård samt därmed förenlig verksamhet.
Address
Valsgärdevägen 2
Email
info@medsys.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 55 | 0 | 0 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | 8 | −10 | −13 | −6 | −7 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 8 | −10 | −13 | −6 | −7 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | 9 | −10 | −13 | −6 | −7 |
| Tax | −2 | 3 | — | — | — |
| Net profit | 7 | −7 | −13 | −6 | −7 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 169 | 111 | 98 | 92 | 96 |
| Equity | 128 | 121 | 109 | 103 | 96 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 41 | 11 | −11 | −11 | 0 |
| Total debt | 41 | 11 | −11 | −11 | — |
EBITDA margin
-721200.0%
This company
15.8%
Market median
-4564657% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-7.1%
This company
18.4%
Market median
-139% vs market
20202024
Net profit margin
-687500.0%
This company
8.1%
Market median
-8487754% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KW Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medsys Sverige AB 
Medsys Box ABBoard members of Medsys Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Wilhelm Johan Olsson | Chief Executive Officer | 0 companies |
| Erik Olof Olsson | Deputy Board Member | 0 companies |
| Emma Miranda Galos | Deputy Board Member | 0 companies |
| Peter Norman Galos | Chairman | 0 companies |